Research Peptides in Los Angeles, CA

Shipping research peptides to Los Angeles

Every Los Angeles order ships from Peptides Factory Direct as a stable lyophilized powder, packed for safe domestic transit to Los Angeles and the wider California research community. Lots are third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC, and a Certificate of Analysis is available on request to support Los Angeles research records.

Research peptide categories shipped to Los Angeles

Los Angeles researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides Los Angeles researchers request most

These are among the most-studied compounds shipped to Los Angeles and the surrounding California research community. Every profile is grounded in the research literature and provided strictly for laboratory context; nothing here is a human-use claim.

Vesugen (KED Vascular Bioregulator) research

Vesugen is a short vascular peptide bioregulator (a tripeptide, KED) from the Khavinson family, studied for endothelial and vessel-wall support signaling in research models. It is the vascular-tissue member of the short-peptide bioregulator group.

Research mechanism. Vesugen research focuses on vascular and endothelial tissue bioregulation - the concept that a tissue-specific short peptide can support normal endothelial function and vessel-wall protein synthesis - within cardiovascular-tissue research models.

Vascular / endothelial research. Studied for endothelial-function and vessel-support endpoints in models.

Cardiovascular-tissue research. Examined in bioregulator research focused on vascular tissue normalization.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator framework.

How it compares. Vesugen is the vascular/endothelial bioregulator, distinct from the organ bioregulator Ovagen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Ovagen, Pinealon) in tissue-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Vesugen research profile → · Specialty peptides

TB-500 (Thymosin Beta-4 fragment) research

TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein involved in actin regulation and cell migration. In research it is valued for its reported ability to travel systemically and reach tissue throughout the body rather than acting only at a local site.

Research mechanism. TB-500 research focuses on its binding to G-actin and its role in cell migration, blood-vessel formation, and the recruitment of repair cells to damaged tissue. By promoting cell motility, it is studied as a driver of slower but deeper regeneration than localized repair peptides.

Deep tissue and muscle recovery research. TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.

Chronic-injury models. Its systemic profile makes it common in chronic and hard-to-reach injury models where a localized peptide would be impractical.

Stacked regeneration studies. It is the standard research partner for BPC-157 in connective-tissue regeneration protocols.

How it compares. Where BPC-157 is studied as fast and local, TB-500 is studied as slower and systemic. Researchers often choose between them based on whether whole-body distribution or site-specific action is the variable of interest.

Research pairings. TB-500 + BPC-157 is the most-studied healing pair in the literature; the two are reported to address complementary repair pathways. TB-500 is banned by WADA, a relevant note for sports-science researchers.

Reference research values. Published research references commonly cite a loading phase of 5-10 mg per week split across 2-3 administrations for 4-6 weeks, followed by a 2-5 mg per week maintenance figure. These are reference values from the literature and are not instructions for any living subject.

Full TB-500 research profile → · Healing & Recovery peptides

Cerebrolysin (neuropeptide mixture) research

Cerebrolysin is a peptide preparation derived from porcine brain tissue, composed of low-molecular-weight neuropeptides and amino acids. It is studied for neurotrophic and neuroprotective endpoints and is used clinically in parts of Europe and Asia.

Research mechanism. Cerebrolysin research focuses on neurotrophic signaling that mimics endogenous nerve-growth factors, with interest in neural repair and cognition endpoints in models.

Neurotrophic research. Studied for nerve-growth and neural-repair endpoints.

Cognitive and recovery research. Examined in models of cognitive decline and neural injury.

Neuroprotection research. Used in neuroprotection study designs.

How it compares. Cerebrolysin is a peptide mixture rather than a single sequence, distinguishing it from Semax, Selank, and Dihexa.

Research pairings. Generally studied as a standalone neurotrophic preparation.

Reference research values. Research references commonly cite 5-10 ml daily or every other day across a 10-30 administration course. Reference values only - an advanced compound.

Full Cerebrolysin research profile → · Cognitive & Neurological peptides

PT-141 (Bremelanotide) research

PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. It is studied for sexual-function endpoints through a central-nervous-system mechanism rather than a vascular one.

Research mechanism. PT-141 research focuses on activation of melanocortin receptors (notably MC4R) in the central nervous system, which is the distinguishing feature versus vascular mechanisms studied for other compounds.

Libido / sexual-function research. Studied for arousal endpoints in both male and female models via CNS signaling.

Melanocortin-pathway research. A model compound for MC4R signaling studies.

Centrally-mediated research. Used where a central rather than vascular mechanism is the variable.

How it compares. Unlike vascular-pathway compounds, PT-141 acts centrally; unlike Melanotan I/II it is studied primarily for sexual-function rather than tanning endpoints.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 1-2 mg administered 45-90 minutes before the modeled endpoint, used as-needed rather than daily. Reference values only.

Full PT-141 research profile → · Sexual Health & Tanning peptides

GHRP-2 (Growth Hormone Releasing Peptide-2) research

GHRP-2 is a synthetic hexapeptide growth-hormone secretagogue, studied as a middle ground between GHRP-6 (strong appetite signaling) and Ipamorelin (selective and clean).

Research mechanism. GHRP-2 activates the GH-secretagogue receptor for GH release, with a reportedly smaller appetite response than GHRP-6 and somewhat more than Ipamorelin in research models.

GH-release research. A potent GHRP for growth-hormone-pulse studies.

Body-composition models. Studied for downstream metabolic endpoints.

GHRH synergy research. Paired with CJC-1295 in stacking studies.

How it compares. GHRP-2 is studied as a balance between GHRP-6 potency/appetite and Ipamorelin selectivity.

Research pairings. GHRP-2 + CJC-1295 is a common research pairing; prolactin is monitored in models.

Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.

Full GHRP-2 research profile → · Growth Hormone & Muscle peptides

DSIP (Delta Sleep-Inducing Peptide) research

DSIP (delta sleep-inducing peptide) is a naturally occurring neuropeptide studied for its reported association with delta-wave sleep and stress regulation. The research literature is mixed, which makes it an active area of investigation.

Research mechanism. DSIP research examines its role in sleep architecture, stress-hormone modulation, and pain endpoints, though the exact mechanism remains a research question.

Sleep research. Studied for sleep-quality and delta-wave endpoints in models.

Stress-regulation research. Examined for stress-hormone modulation.

Pain-modulation research. Used in exploratory pain-endpoint designs.

How it compares. DSIP is studied specifically for sleep and stress endpoints, distinct from the hormone and cognitive peptides.

Research pairings. Generally studied as a standalone sleep-research peptide.

Reference research values. Research references commonly cite 100-300 mcg before rest periods, used as-needed. Reference values only.

Full DSIP research profile → · Specialty peptides

CJC-1295 (with or without DAC) research

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.

Research mechanism. CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.

Growth-hormone release research. The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.

Body-composition models. It is studied for downstream effects on muscle and fat metabolism in research models.

GHRH + GHRP synergy studies. CJC-1295 + Ipamorelin is one of the most-studied research pairings for amplified GH pulses.

How it compares. The DAC form trades fewer administrations for a longer, flatter profile; the no-DAC form is studied for sharper, more physiologic pulses. Choice depends on the research kinetics of interest.

Research pairings. CJC-1295 (no DAC) + Ipamorelin is the canonical research pairing; the GHRH analog and the GHRP are reported to act through complementary receptors.

Reference research values. Research references commonly cite 200-300 mcg of the no-DAC form before rest periods on a 5-7 day schedule, or 1-2 mg of the DAC form one to two times weekly. Reference values only.

Full CJC-1295 research profile → · Growth Hormone & Muscle peptides

Pinealon (EDR Tripeptide) research

Pinealon is a short synthetic peptide bioregulator (a tripeptide) from the Khavinson family of peptide bioregulators. It is studied for neuroprotective, pineal/circadian, and cognitive-support concepts in research models, where short peptides are investigated for tissue-specific gene-regulatory activity.

Research mechanism. Pinealon research centers on peptide bioregulation in neural tissue - the idea that short peptides can influence gene expression and protein synthesis in a tissue-specific way - alongside antioxidant and neuroprotective signaling and pineal/circadian-axis variables.

Cognitive research. Studied for learning, memory, and cognitive-function endpoints in models.

Neuroprotection research. Examined for protection of neural tissue against oxidative and ischemic stress in study models.

Circadian / pineal research. Investigated for pineal-axis and sleep-regulation variables.

How it compares. Pinealon is neuro/cognitive-focused, distinguishing it from telomere-focused Epithalon and the organ-support bioregulators Ovagen and Vesugen.

Research pairings. Studied alongside other Khavinson bioregulators such as Epithalon in longevity-oriented research designs.

Reference research values. Research references commonly cite 1-3 mg daily in short cognitive/longevity-oriented study cycles. Reference values only - not for human or animal use.

Full Pinealon research profile → · Cognitive & Neurological peptides

Ipamorelin (selective GHRP) research

Ipamorelin is a pentapeptide and a selective growth-hormone secretagogue (a GHRP). In research it is valued for being one of the most selective GHRPs, reported to stimulate GH release with minimal effect on cortisol or prolactin compared with older GHRPs.

Research mechanism. Ipamorelin acts on the ghrelin/GH-secretagogue receptor to trigger growth-hormone release. Its selectivity is the central research interest, since it isolates the GH-release variable without confounding hormonal signals.

Selective GH-release research. Used as a clean GHRP in studies where minimizing cortisol/prolactin interference matters.

GHRH synergy models. Most often studied with CJC-1295 to amplify GH pulses.

Body-composition and recovery research. Downstream metabolic and recovery endpoints are studied in models.

How it compares. Compared with GHRP-6 and GHRP-2, Ipamorelin is studied as the most selective option with the least off-target hormonal signaling; compared with Hexarelin it is gentler but less potent.

Research pairings. Ipamorelin + CJC-1295 (no DAC) is the standard research stack for amplified, relatively clean GH release.

Reference research values. Research references commonly cite 200-300 mcg before rest periods on a 5-7 day schedule. Reference values only.

Full Ipamorelin research profile → · Growth Hormone & Muscle peptides

HCG (Human Chorionic Gonadotropin) research

HCG (human chorionic gonadotropin) is a glycoprotein hormone that mimics luteinizing hormone. It has a well-established research profile and is studied for its downstream effects on gonadal hormone production.

Research mechanism. HCG research focuses on LH-receptor activation, stimulating gonadal tissue in research models - the downstream counterpart to upstream GnRH and Kisspeptin signaling.

Reproductive-hormone research. Studied for gonadal-hormone and fertility endpoints.

LH-analog research. A model compound for LH-receptor studies.

Hormone-axis research. Examined in models of endogenous hormone support.

How it compares. HCG mimics LH downstream, while Gonadorelin and Kisspeptin act upstream in the same axis.

Research pairings. Studied alongside GnRH peptides in hormone-axis research designs. Banned by WADA - relevant for sports-science researchers.

Reference research values. Research references commonly cite 250-500 IU two to three times weekly. Reference values only.

Full HCG research profile → · Specialty peptides

AOD 9604 (HGH Fragment 176-191) research

AOD 9604 is a modified fragment (residues 176-191) of human growth hormone, representing the region associated with fat metabolism. It is studied because it isolates the lipolytic portion of GH without the growth-signaling or glucose effects of the whole hormone.

Research mechanism. AOD 9604 research focuses on stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis without acting on the IGF-1 axis or blood glucose - the defining research feature.

Lipolysis research. Studied specifically for fat-metabolism endpoints in models.

Metabolic models without glucose effect. Useful where researchers want fat signaling isolated from blood-sugar variables.

Stubborn-fat research. Examined in models of resistant adipose tissue.

How it compares. Unlike GLP-1 peptides that act on appetite, AOD 9604 isolates the fat-metabolism portion of GH and does not affect blood sugar - a distinct research mechanism.

Research pairings. Sometimes studied alongside GH-secretagogues in metabolic research designs.

Reference research values. Research references commonly cite 300-600 mcg daily (often modeled in a fasted window) over 12-16 week study periods. Reference values only.

Full AOD 9604 research profile → · Fat Loss & Weight Management peptides

N-Acetyl Semax Amidate (potent Semax analog) research

N-Acetyl Semax Amidate is a modified version of Semax with acetylation and amidation that the literature associates with greater potency and a longer active window in cognitive-research models.

Research mechanism. Like Semax, it is studied for BDNF and nerve-growth-factor signaling and monoamine modulation, with the modifications extending stability and duration in models.

Advanced cognitive research. Studied for focus, learning, and mental-clarity endpoints with a longer duration.

Neuroprotection research. Examined in neural-stress and recovery models.

BDNF-signaling research. A more stable model compound for neurotrophic studies.

How it compares. It is studied as more potent and longer-lasting than standard Semax, suited to demanding cognitive-research models.

Research pairings. Studied alongside Selank in cognitive-research designs.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full N-Acetyl Semax Amidate research profile → · Cognitive & Neurological peptides

Dihexa (high-potency nootropic) research

Dihexa is a synthetic peptide derived from angiotensin IV, studied for its reported high potency in promoting synaptic connections (synaptogenesis). The literature describes it as extremely potent relative to BDNF in model systems, with limited human data.

Research mechanism. Dihexa research focuses on the hepatocyte-growth-factor / c-Met system and synaptogenesis, with interest in memory and cognition endpoints.

Synaptogenesis research. Studied for formation of new synaptic connections in models.

Memory and cognition research. Examined for learning and memory endpoints.

Neurodegeneration models. Used in exploratory neurodegeneration research.

How it compares. Dihexa is studied as far more potent than Semax/Selank in model systems but with much less data, making it a specialized research tool.

Research pairings. Generally studied as a standalone high-potency nootropic.

Reference research values. Research references commonly cite 5-10 mg daily in 4-8 week cycled windows. Reference values only - an advanced compound with limited data; use caution.

Full Dihexa research profile → · Cognitive & Neurological peptides

Research applications studied in Los Angeles

• Vascular / endothelial research (Vesugen). Studied for endothelial-function and vessel-support endpoints in models.
• Deep tissue and muscle recovery research (TB-500). TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.
• Neurotrophic research (Cerebrolysin). Studied for nerve-growth and neural-repair endpoints.
• Libido / sexual-function research (PT-141). Studied for arousal endpoints in both male and female models via CNS signaling.
• GH-release research (GHRP-2). A potent GHRP for growth-hormone-pulse studies.

How Los Angeles researchers order and store material

Ordering for a Los Angeles lab is done in the Peptides Factory Direct portal, with one-time or recurring options and a checkout confirmation of laboratory research use. Material ships to Los Angeles as a lyophilized powder for refrigerated storage; after reconstitution keep it cold and use within the standard research window. Los Angeles researchers remain responsible for compliance with applicable law, and nothing supplied is for human or animal consumption. Open the order portal.

Why Los Angeles researchers choose Peptides Factory Direct

What sets Peptides Factory Direct apart for Los Angeles researchers is documentation, not claims. Each Los Angeles order is third-party tested to a 99%+ purity target, ships with lot tracking and a COA on request, and arrives quickly by domestic carrier. The same catalog, purity standard, and research-use terms apply whether material ships to Los Angeles or anywhere else in the US.

Nearby California research areas we ship to

Frequently asked questions

All California cities · All states · Research guides

External references: California (Wikipedia) · U.S. Census Bureau